āagmanLoginNot investment advice. Data and computed figures, for information only.
Akums Drugs & Pharmaceuticals Ltd
₹731.45
−₹18.35 (−2.45%)
NSE · 16 Oct 2026, close
Market Cap
₹11,834 Cr
CMP
₹731.45
52-wk High / Low
₹839 / 409
P/E
38.8
P/B
3.6
Book Value
₹211.0
Div Yield
0.13%
ROCE
15.0%
ROE
8.5%
Face Value
₹2
D/E
0.05
Price+58.2% over 1Y
āagman read
Computed by āagmanPiotroski F-Score
5
/ 9
5 of 9 F-score tests passed
Graham Number
₹277
√(22.5 × EPS × book value per share)
ROIC
7.1%
vs 11.2% sector median
Cash flow to profit
4.61
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
+240
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
8.0%
ROE × earnings retention ratio
ROE stability
20.0
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom +0.00FII +0.53DII −0.92
Latest quarter vs the previous one
Cash-accrual divergence
−19.4%
of assets
Low = accruals track cash flow
Strengths
+Borrowings are down 26.3% since FY2016 (213 to 157)
+Price trades above its 200-day moving average (1.2x)
+PE of 38.8x is below the sector median of 45.9x
Watch-outs
−Latest ROCE of 15% trails the sector median of 17%
Peer comparison
| Name | P/E | Mar Cap ₹ Cr | ROCE % | ROE % |
|---|
Quarterly results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 970 | 1,181 | 1,083 | 944 | 1,019 | 1,033 | 1,010 | 1,056 | 1,024 | 1,018 | 1,160 | 1,158 | 1,167 |
| Expenses | 1,095 | 1,029 | 989 | 941 | 891 | 912 | 889 | 962 | 895 | 923 | 1,013 | 1,006 | 992 |
| Operating Profit | −125 | 152 | 93 | 3 | 128 | 121 | 121 | 94 | 129 | 94 | 147 | 152 | 175 |
| OPM % | −12.9% | 12.9% | 8.6% | 0.3% | 12.6% | 11.7% | 12.0% | 8.9% | 12.6% | 9.2% | 12.7% | 13.1% | 15.0% |
| Other Income | 8 | −21 | 10 | 10 | 7 | 17 | 19 | 26 | 27 | 32 | 16 | 34 | 30 |
| Interest | 12 | 14 | 12 | 12 | 13 | 12 | 5 | 5 | 23 | 23 | 24 | 24 | 25 |
| Depreciation | 30 | 30 | 32 | 34 | 34 | 35 | 45 | 40 | 37 | 38 | 40 | 40 | 41 |
| Profit before tax | −159 | 87 | 59 | −33 | 87 | 92 | 91 | 75 | 96 | 66 | 100 | 121 | 139 |
| Net Profit | −187 | 33 | 195 | −39 | 61 | 67 | 66 | 150 | 65 | 43 | 68 | 81 | 101 |
| EPS (₹) | −13.16 | 2.22 | 13.54 | −2.89 | 4.08 | 4.14 | 4.14 | 9.38 | 4.03 | 2.59 | 4.21 | 5.38 | 6.35 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,464 | 1,651 | 2,414 | 2,723 | 3,672 | 3,655 | 4,178 | 4,118 | 4,359 | 4,502 |
| Expenses | 1,340 | 1,507 | 2,240 | 2,485 | 3,761 | 3,361 | 4,055 | 3,654 | 3,837 | 3,934 |
| Operating Profit | 124 | 144 | 174 | 238 | −89 | 294 | 123 | 465 | 522 | 568 |
| OPM % | 8.5% | 8.7% | 7.2% | 8.7% | −2.4% | 8.0% | 2.9% | 11.3% | 12.0% | 12.6% |
| Other Income | 6 | 6 | 26 | 11 | 7 | 15 | 8 | 69 | 108 | 112 |
| Interest | 23 | 22 | 20 | 7 | 17 | 46 | 51 | 35 | 94 | 96 |
| Depreciation | 31 | 38 | 67 | 70 | 95 | 113 | 126 | 153 | 155 | 159 |
| Profit before tax | 77 | 89 | 114 | 172 | −193 | 150 | −45 | 345 | 382 | 426 |
| Net Profit | 43 | 61 | 44 | 123 | −251 | 98 | 1 | 344 | 256 | 293 |
| EPS (₹) | 366.55 | 523.23 | 335.61 | 943.49 | −35.30 | 6.63 | −0.28 | 21.49 | 16.21 | 18.53 |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 1 | 14 | 29 | 29 | 31 | 31 | — |
| Reserves | 493 | 628 | 721 | 884 | 608 | 689 | 681 | 3,016 | 3,283 | — |
| Borrowings | 255 | 213 | 175 | 130 | 395 | 619 | 565 | 88 | 157 | — |
| Other Liabilities | 293 | 318 | 1,140 | 1,137 | 2,033 | 1,905 | 2,229 | 960 | 1,958 | — |
| Total Liabilities | 1,042 | 1,161 | 2,037 | 2,152 | 3,050 | 3,241 | 3,504 | 4,095 | 5,429 | — |
| Fixed Assets | 444 | 501 | 645 | 904 | 1,021 | 1,097 | 1,191 | 1,397 | 1,456 | — |
| CWIP | 0 | 11 | 57 | 17 | 31 | 103 | 195 | 163 | 177 | — |
| Investments | 0 | 18 | 6 | 20 | 0 | 0 | 0 | 0 | 0 | — |
| Other Assets | 598 | 632 | 1,329 | 1,212 | 1,998 | 2,041 | 2,118 | 2,535 | 3,796 | — |
| Total Assets | 1,042 | 1,161 | 2,037 | 2,152 | 3,050 | 3,241 | 3,504 | 4,095 | 5,429 | — |
Cash Flows
| Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 72 | 89 | 28 | 131 | 32 | 177 | 498 | 465 | 1,181 |
| Cash from Investing Activity | −150 | −123 | −190 | −109 | −235 | −305 | −331 | −548 | −930 |
| Cash from Financing Activity | 66 | 37 | 233 | −91 | 236 | 125 | −108 | 73 | 34 |
| Net Cash Flow | −11 | 4 | 71 | −70 | 33 | −4 | 59 | −10 | 285 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| ROCE % | — | 14.0 | — | 20.0 | −16.0 | 22.0 | 2.0 | 16.0 | 15.0 |
| ROE % | — | — | — | — | — | — | — | — | 8.5 |
| EPS (₹) | 366.55 | 523.23 | 335.61 | 943.49 | −35.30 | 6.63 | −0.28 | 21.49 | 16.21 |
| Book Value (₹) | — | — | — | — | — | — | — | — | 211.0 |
| Face Value (₹) | — | — | — | — | — | — | — | — | 2 |
| P/E | — | — | — | — | — | — | — | — | 38.8 |
| Div Yield % | — | — | — | — | — | — | — | — | 0.13 |
| NPM % | 2.9 | 3.7 | 1.8 | 4.5 | −6.8 | 2.7 | 0.0 | 8.2 | 5.7 |
| OPM % | 8.0 | 9.0 | 7.0 | 9.0 | −2.4 | 8.0 | 3.0 | 11.0 | 12.0 |
| D/E | 0.52 | 0.34 | 0.24 | 0.15 | 0.64 | 0.86 | 0.80 | 0.03 | 0.05 |
| P/B | — | — | — | — | — | — | — | — | 3.6 |
Growth
Compounded sales growth
10 years+10.0%
5 years+10.0%
3 years+6.0%
TTM+9.0%
Compounded profit growth
10 years+16.0%
5 years+16.0%
3 years+29.0%
TTM−7.0%
Stock price CAGR
Last year+69.0%
Return on equity
5 years6.0%
3 years10.0%
Last year8.0%
Documents
Corporate actions
3 Jul 2026DIVIDENDDividend - Re 1 Per Share/Special Dividend - Rs 2 Per Share—
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman